Indication
Sickle Cell Disorder
1 clinical trial
5 products
1 drug
Clinical trial
Pilot Study to Evaluate the Safety and Feasibility of Induction of Mixed Chimerism in Sickle Cell Disease Patients With COH-MC-17: a Non-Myeloablative, Conditioning Regimen and CD4+ T-cell-depleted Haploidentical Hematopoietic TransplantStatus: Active (not recruiting), Estimated PCD: 2024-11-17
Drug
cyclophosphamideProduct
PentostatinProduct
TacrolimusProduct
Mycophenolate